Analystreport

Atossa Genetics (NASDAQ:ATOS) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com